Moteur de recherche d’entreprises européennes
Registre de Transparence de l'Union Européenne Eutr09/05/2026 Registre de Transparence de l'Union Européenne
Vue d’ensemble
Texte
Daiichi Sankyo Europe GmbH
Registration ID: 284628150205-20 Registration Date: 2023-05-26 Last Update Date: 2026-05-08 Acronym: DSE Entity Form: GmbH Website: https://www.daiichi-sankyo.eu/ Registration Category: Companies & groups
Head Office
- Address:
?? Rue sans nom, 81379 Munich, Allemagne , GERMANY - Phone: +49 8978080
EU Office
- Address:
?? Rue sans nom, 81379 Munich, Allemagne , GERMANY - Phone: +49 8978080
Goals
Daiichi Sankyo is a research-based global pharmaceutical company headquartered in Japan with operations in more than 20 countries worldwide. The European headquarters are located in Munich; mainly active in the areas of cardiovascular diseases & oncology.
Levels of Interest
- Global
EU Legislative Proposals
Daiichi Sankyo is interested in EU initiatives and political developments that relate to our focus in research, development, manufacturing and business: innovative medicines. This includes topics such as health policy, global health, relevant pharmaceutical legislation including General Pharmaceutical Legislation, Biotech Act I, Urban Wastewater Treatment Directive, Critical Medicines Act, EU Safe Hearts Plan, clinical trials, trade, IP, environment and sustainability.
Communication Activities
Sponsorship and report of Economist World Cancer Series - session on Women Centric Breast Cancer Care. European Health Forum Gastein with session on NCD's and women's health, European Business Summit - session on EU Cardiovascular Health Plan, Online roundtable with European Cancer Organisation on breast cancer - sponsored.
Inter or Unofficial Groupings
N/A
Members
- Accredited Persons to the European Parliament: 1
- Number of Members: 3
- FTE: 0.7
Interests
- Business and industry
- Digital economy and society
- Public health
- Research and innovation
- Trade
Structure
- Is Member Of: https://www.daiichi-sankyo.eu/
- Organisation Members:
- Efpia (https://www.efpia.eu/)
- EPC (https://www.epc.eu/en)
- European Cancer Organisation (E.C.O.) (https://www.europeancancer.org/)
- Japanese Business Council (https://www.jbce.org/en/)
- All.Can (https://www.all-can.org/)
Interest Represented
Promotes their own interests or the collective interests of their members
Financial Data
Closed Year (2025-04-01 to 2026-03-01)
- Total Costs: €900,000 - €999,999
- Intermediaries:
- Acumen Public Affairs: €50,000 - €99,999
Current Year
- Intermediaries:
- Acumen Public Affairs
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Daiichi Sankyo Europe GmbH, Munich, Allemagne.
